<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR30">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>QP</given-names>
   </name>
   <name>
    <surname>Ding</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>ML</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Cheng</surname>
    <given-names>JQ</given-names>
   </name>
  </person-group>
  <article-title>Reevaluation of the post-marketing safety of Xuebijing injection based on real-world and evidence-based evaluations</article-title>
  <source>Biomed Pharmacother</source>
  <year>2019</year>
  <volume>109</volume>
  <fpage>1523</fpage>
  <lpage>1531</lpage>
  <pub-id pub-id-type="doi">10.1016/j.biopha.2018.10.190</pub-id>
  <?supplied-pmid 30551404?>
  <pub-id pub-id-type="pmid">30551404</pub-id>
 </element-citation>
</ref>
